Augmenix
Augmenix company that focuses on the development and commercialization of radiation oncology products using its hydrogel technology. Augmenix was founded in 2007 and is headquartered in Massachusetts.
Last updated on
About Augmenix
Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$63MCategory
Location
City
BedfordState
MassachusettsCountry
United StatesAugmenix
Find your buyer within Augmenix
Tech Stack (0)
